We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCRDU
2601
DELISTED
Decarbonization Plus Acquisition Corporation IV Unit
DCRDU
-77,617
Closed -$825K
CINC
2602
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
-13,718
Closed -$450K
CTAQU
2603
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
-68,357
Closed -$679K
VIVO
2604
DELISTED
Meridian Bioscience Inc
VIVO
-105,495
Closed -$3.33M
DNZ.WS
2605
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
-12,719
Closed -$126K
NAACU
2606
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
-12,827
Closed -$128K
JCICU
2607
DELISTED
Jack Creek Investment Corp. Units
JCICU
-65,768
Closed -$660K
JCICW
2608
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
-16,744
Closed -$167K
TCDA
2609
DELISTED
Tricida, Inc. Common Stock
TCDA
-92,700
Closed -$276K
TCDA
2610
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
-419,400
Closed -$4.39M
PKBO
2611
DELISTED
Peak Bio, Inc. Common Stock
PKBO
-100,000
Closed -$999K
DRAYW
2612
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
-24,000
Closed -$240K
POSH
2613
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
-45,133
Closed -$707K
SPIR.WS
2614
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
-15,094
Closed -$16K
GLBLU
2615
DELISTED
Cartesian Growth Corporation Unit
GLBLU
-10,372
Closed -$104K
LJAQW
2616
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
-15,625
Closed -$157K
ASAX
2617
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
-350,000
Closed -$3.44M
GIIX
2618
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
-292,179
Closed -$2.88M
ASAXW
2619
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
-57,192
Closed -$563K
CLAS.U
2620
DELISTED
Class Acceleration Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
CLAS.U
-10,437
Closed -$103K
FACA
2621
DELISTED
Figure Acquisition Corp. I
FACA
-69,295
Closed -$683K
MDH.U
2622
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
-65,913
Closed -$650K
SPKAR
2623
DELISTED
SPK Acquisition Corp. Right
SPKAR
-356,610
Closed -$63K
ISAA
2624
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
-91,607
Closed -$910K
LFG
2625
DELISTED
Archaea Energy Inc.
LFG
-57,022
Closed -$1.03M

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.